Evidence map›Paper›PMID 39298537›Full record

ArticlePloS one2024

The oral intake of specific Bioactive Collagen Peptides (BCP) improves gait and quality of life in canine osteoarthritis patients-A translational large animal model for a nutritional therapy option.

Britta Dobenecker, Linda Franziska Böswald, Sven Reese, Stephanie Steigmeier-Raith, Lukas Trillig, Steffen Oesser, Michael Schunck, Andrea Meyer-Lindenberg, Jutta Hugenberg

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Britta DobeneckerDepartment of Veterinary Science, Ludwig-Maximilians-Universität München, München, Germany.ORCID 0000-0003-0534-4219
Linda Franziska BöswaldDepartment of Veterinary Science, Ludwig-Maximilians-Universität München, München, Germany.
Sven ReeseDepartment of Veterinary Science, Ludwig-Maximilians-Universität München, München, Germany.
Stephanie Steigmeier-RaithClinic for Small Animal Surgery and Reproduction, Ludwig-Maximilians-Universität München, München, Germany.
Lukas TrilligClinic for Small Animal Surgery and Reproduction, Ludwig-Maximilians-Universität München, München, Germany.
Steffen OesserCollagen Research Institute, Kiel, Germany.
Michael SchunckCollagen Research Institute, Kiel, Germany.
Andrea Meyer-LindenbergClinic for Small Animal Surgery and Reproduction, Ludwig-Maximilians-Universität München, München, Germany.
Jutta HugenbergGelita AG, Ebersbach, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOsteoarthritis (OA) is the most common joint disorder in humans and dogs. Due to its chronic progressive nature, the predominant clinical signs after a certain point are pain and immobility. The similar pathogenesis allows conclusions to be drawn from canine to human OA. Current treatments are limited and often attempt to treat OA symptoms rather than improve joint structure and function. Collagen hydrolysates as oral supplements are a promising therapeutic option to achieve this advanced therapeutic aim in both species. The effects of oral supplementation were therefore investigated in canine OA patients.

methodIn a systematic, placebo-controlled, double-blind interventional study in 31 dogs with naturally occurring OA, the efficacy of oral supplementation of specific bioactive collagen peptides (BCP) was tested in comparison to the approved combination of the active substances omega-3 fatty acids and vitamin E. The dogs were examined on a horizontal treadmill with 4 integrated piezoelectric force plates at the beginning and end of a twelve-week test period. At both points, the owners completed a specific questionnaire containing the validated Canine Brief Pain Inventory (CBPI) and the dogs were fitted with accelerometers to record total daily activity data.

resultsOnly the oral supplementation of BCP resulted in a significant improvement of several kinetic parameters measured using a force-plate fitted treadmill, and the quality of life assessed by CBPI, while accelerometry was unaffected by the intervention.

conclusionThe results of this three-month BCP supplementation study using objective measurement parameters in dogs with naturally occurring OA demonstrate an efficacy, suggesting the therapeutic use of BCP in canine OA patients and demonstrating the relevance of this collagen hydrolysate formulation for the treatment of OA in human patients as well.

Indexed as

CollagenDietary SupplementsGaitOsteoarthritisQuality of LifeAdministration, OralAnimalsDisease Models, AnimalDog DiseasesDogsDouble-Blind MethodFemaleMalePeptidesCollagenPeptides

Identifiers

PMID39298537
PMCPMC11412516

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.